Comprehensive Analysis of Potential Biomarkers of Acute Lymphoblastic Leukemia in Children by Using a Competing Endogenous RNA Network
Acute lymphoblastic leukemia (ALL) is the most serious hematological carcinoma in adolescents. The significance of long noncoding RNAs (lncRNAs) and their regulative role in the proliferation and differentiation of myeloid cells in cancer has been recently reported. Nevertheless, key RNAs and the re...
Saved in:
Published in | Journal of oncology Vol. 2022; pp. 1 - 15 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Egypt
Hindawi
06.04.2022
John Wiley & Sons, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Acute lymphoblastic leukemia (ALL) is the most serious hematological carcinoma in adolescents. The significance of long noncoding RNAs (lncRNAs) and their regulative role in the proliferation and differentiation of myeloid cells in cancer has been recently reported. Nevertheless, key RNAs and the regulatory mechanism of competitive endogenous RNA (ceRNA) network affected by pediatric ALL are not fully illustrated. In this study, phase 2 and 3 pediatric ALL RNA profiles were extracted from the TARGET database and used to identify lncRNAs, microRNAs, and messenger RNAs in high-risk ALL and reconstruct the sponge ceRNA regulatory network. Results indicated that 44 lncRNAs, 25 miRNAs, and 115 mRNA were up/downregulated. Functional analysis with differentially expressed RNAs (DERNAs) showed enriched significant signaling pathways, including PI3K-Akt and p53 signaling cascades and other pathways associated with the tumor. Seventeen differential hub RNAs, including LINC00909, BZRAP1-AS1, C17orf76-AS1, HCG11, MIAT, SNHG5, SNHG15, and TP73-AS1, were identified. The Cox model of correlation indicated that 14 of these RNAs were associated with the progression of pediatric ALL. These findings would help clarify the regulatory role of several lncRNAs as well as provide insights into the leukemogenesis of pediatric ALL to further explore novel prognostic markers/therapeutic targets for ALL. |
---|---|
AbstractList | Acute lymphoblastic leukemia (ALL) is the most serious hematological carcinoma in adolescents. The significance of long noncoding RNAs (lncRNAs) and their regulative role in the proliferation and differentiation of myeloid cells in cancer has been recently reported. Nevertheless, key RNAs and the regulatory mechanism of competitive endogenous RNA (ceRNA) network affected by pediatric ALL are not fully illustrated. In this study, phase 2 and 3 pediatric ALL RNA profiles were extracted from the TARGET database and used to identify lncRNAs, microRNAs, and messenger RNAs in high-risk ALL and reconstruct the sponge ceRNA regulatory network. Results indicated that 44 lncRNAs, 25 miRNAs, and 115 mRNA were up/downregulated. Functional analysis with differentially expressed RNAs (DERNAs) showed enriched significant signaling pathways, including PI3K-Akt and p53 signaling cascades and other pathways associated with the tumor. Seventeen differential hub RNAs, including LINC00909, BZRAP1-AS1, C17orf76-AS1, HCG11, MIAT, SNHG5, SNHG15, and TP73-AS1, were identified. The Cox model of correlation indicated that 14 of these RNAs were associated with the progression of pediatric ALL. These findings would help clarify the regulatory role of several lncRNAs as well as provide insights into the leukemogenesis of pediatric ALL to further explore novel prognostic markers/therapeutic targets for ALL. Acute lymphoblastic leukemia (ALL) is the most serious hematological carcinoma in adolescents. The significance of long noncoding RNAs (lncRNAs) and their regulative role in the proliferation and differentiation of myeloid cells in cancer has been recently reported. Nevertheless, key RNAs and the regulatory mechanism of competitive endogenous RNA (ceRNA) network affected by pediatric ALL are not fully illustrated. In this study, phase 2 and 3 pediatric ALL RNA profiles were extracted from the TARGET database and used to identify lncRNAs, microRNAs, and messenger RNAs in high-risk ALL and reconstruct the sponge ceRNA regulatory network. Results indicated that 44 lncRNAs, 25 miRNAs, and 115 mRNA were up/downregulated. Functional analysis with differentially expressed RNAs (DERNAs) showed enriched significant signaling pathways, including PI3K-Akt and p53 signaling cascades and other pathways associated with the tumor. Seventeen differential hub RNAs, including LINC00909, BZRAP1-AS1, C17orf76-AS1, HCG11, MIAT, SNHG5, SNHG15, and TP73-AS1, were identified. The Cox model of correlation indicated that 14 of these RNAs were associated with the progression of pediatric ALL. These findings would help clarify the regulatory role of several lncRNAs as well as provide insights into the leukemogenesis of pediatric ALL to further explore novel prognostic markers/therapeutic targets for ALL.Acute lymphoblastic leukemia (ALL) is the most serious hematological carcinoma in adolescents. The significance of long noncoding RNAs (lncRNAs) and their regulative role in the proliferation and differentiation of myeloid cells in cancer has been recently reported. Nevertheless, key RNAs and the regulatory mechanism of competitive endogenous RNA (ceRNA) network affected by pediatric ALL are not fully illustrated. In this study, phase 2 and 3 pediatric ALL RNA profiles were extracted from the TARGET database and used to identify lncRNAs, microRNAs, and messenger RNAs in high-risk ALL and reconstruct the sponge ceRNA regulatory network. Results indicated that 44 lncRNAs, 25 miRNAs, and 115 mRNA were up/downregulated. Functional analysis with differentially expressed RNAs (DERNAs) showed enriched significant signaling pathways, including PI3K-Akt and p53 signaling cascades and other pathways associated with the tumor. Seventeen differential hub RNAs, including LINC00909, BZRAP1-AS1, C17orf76-AS1, HCG11, MIAT, SNHG5, SNHG15, and TP73-AS1, were identified. The Cox model of correlation indicated that 14 of these RNAs were associated with the progression of pediatric ALL. These findings would help clarify the regulatory role of several lncRNAs as well as provide insights into the leukemogenesis of pediatric ALL to further explore novel prognostic markers/therapeutic targets for ALL. |
Audience | Academic |
Author | Xu, Lu-Hong Lin, Xiao-Ying Huang, Yan Chen, Hai-Lei Shen, Miao-Na Liu, Yong Yuen, Ka-Yuk Huang, Qian-Wen |
AuthorAffiliation | 3 Department of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China 1 Hematologic Laboratory of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China 2 Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China |
AuthorAffiliation_xml | – name: 1 Hematologic Laboratory of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China – name: 2 Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China – name: 3 Department of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China |
Author_xml | – sequence: 1 givenname: Xiao-Ying surname: Lin fullname: Lin, Xiao-Ying organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn – sequence: 2 givenname: Ka-Yuk surname: Yuen fullname: Yuen, Ka-Yuk organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn – sequence: 3 givenname: Hai-Lei surname: Chen fullname: Chen, Hai-Lei organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn – sequence: 4 givenname: Miao-Na surname: Shen fullname: Shen, Miao-Na organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn – sequence: 5 givenname: Yan surname: Huang fullname: Huang, Yan organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn – sequence: 6 givenname: Qian-Wen surname: Huang fullname: Huang, Qian-Wen organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn – sequence: 7 givenname: Yong orcidid: 0000-0002-8324-3635 surname: Liu fullname: Liu, Yong organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn – sequence: 8 givenname: Lu-Hong orcidid: 0000-0002-3695-6990 surname: Xu fullname: Xu, Lu-Hong organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene RegulationSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35432537$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktv1DAUhS1URNuBHWtkiQ0SDHX8SrJBCqPykEYFIbq2nOR6xh3HHuyk1fwBfjdJZyilEqx8ZX8-5x77nqIjHzwg9Dwjb7NMiDNKKD3jQjJB2SN0kskinxdckKN79TE6TemKEMlJKZ-gYyY4o4LlJ-jnInTbCGvwyV4Drrx2u2QTDgZ_DT343mqH39vQ6biBeLtfNUMPeLnrtutQO5162-AlDBvorMbW48XaujaCx_UOXybrV1jjyQX6qT73bViBD0PC3y4qfAH9TYibp-ix0S7Bs8M6Q5cfzr8vPs2XXz5-XlTLecNz2c85lbI0kJd13UrBSA5FWxSSM05LWeZ1a5ipua45AM9KwRowBSvazEjDNKkZm6F3e93tUHfQNmPAqJ3aRjsG3Kmgrfr7xNu1WoVrVRKSSy5HgVcHgRh-DJB61dnUgHPaw5hJUSkoYZxIOqIvH6BXYYjjA99SGc9ozss_1Eo7UNabMPo2k6iq8smUkDHIDL243_ddw78_cgTe7IEmhpQimDskI2qaEzXNiTrMyYjTB3hje93bMKW27l-XXu8vra1v9Y39v8UvP-XMlw |
CitedBy_id | crossref_primary_10_3389_fonc_2023_1108564 crossref_primary_10_3390_ijms251810210 |
Cites_doi | 10.2147/OTT.S223321 10.1007/s00011-020-01345-x 10.1016/j.biopha.2018.10.046 10.1016/j.ccell.2016.05.007 10.1056/NEJMra052603 10.1080/15384101.2017.1407893 10.1002/jgm.3074 10.1186/s13045-016-0344-4 10.1002/jcb.26231 10.1089/dna.2016.3533 10.1016/j.canlet.2019.04.030 10.1186/s12943-017-0692-x 10.1038/s41419-019-1479-3 10.2139/ssrn.3844927 10.1016/j.biopha.2019.108965 10.3324/haematol.2018.199364 10.3892/or.2016.5147 10.1177/0963689719887370 10.1016/j.leukres.2019.106265 10.1038/bcj.2017.53 10.3390/ijms20020412 10.1080/21691401.2019.1608221 10.1002/jcp.27393 10.3389/fphar.2016.00491 10.1186/s12967-019-1882-7 10.1002/jcb.27918 10.1056/NEJMra1400972 10.3389/fgene.2021.656042 10.1038/leu.2013.226 10.1038/onc.2014.131 |
ContentType | Journal Article |
Copyright | Copyright © 2022 Xiao-Ying Lin et al. COPYRIGHT 2022 John Wiley & Sons, Inc. Copyright © 2022 Xiao-Ying Lin et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2022 Xiao-Ying Lin et al. 2022 |
Copyright_xml | – notice: Copyright © 2022 Xiao-Ying Lin et al. – notice: COPYRIGHT 2022 John Wiley & Sons, Inc. – notice: Copyright © 2022 Xiao-Ying Lin et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2022 Xiao-Ying Lin et al. 2022 |
DBID | RHU RHW RHX AAYXX CITATION NPM 3V. 7RV 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S NAPCQ PHGZM PHGZT PIMPY PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1155/2022/4563523 |
DatabaseName | Hindawi Publishing Complete Hindawi Publishing Subscription Journals Hindawi Publishing Open Access CrossRef PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef PubMed Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: RHX name: Hindawi Publishing Open Access url: http://www.hindawi.com/journals/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1687-8450 |
Editor | Zhong, Wei long |
Editor_xml | – sequence: 1 givenname: Wei long surname: Zhong fullname: Zhong, Wei long |
EndPage | 15 |
ExternalDocumentID | PMC9007646 A700760095 35432537 10_1155_2022_4563523 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Guangdong Basic and Applied Basic Research Foundation grantid: 2020A1515010312 |
GroupedDBID | --- 188 29L 2WC 4.4 53G 5GY 5VS 7RV 7X7 8FI 8FJ AAFWJ AAJEY AAWTL ABDBF ABUWG ADBBV ADRAZ AFKRA AINHJ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR CCPQU DIK E3Z EBD EBS EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IEA IHR IHW INH INR ITC KQ8 M48 NAPCQ O5R OK1 PIMPY RHU RHW RHX RPM TR2 TUS UKHRP ~8M 0R~ 24P AAYXX ACCMX ALIPV CITATION H13 OVT PGMZT PHGZM PHGZT 2UF ACUHS CEFSP CNMHZ EJD IL9 NPM O5S UZ5 3V. 7XB 8FK AAMMB AEFGJ AGXDD AIDQK AIDYY AZQEC DWQXO K9. PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c476t-42669fe79bbd65307e8d88643429697bdf3fb4ab4ee41953cef838d1f6f3a0b33 |
IEDL.DBID | M48 |
ISSN | 1687-8450 |
IngestDate | Thu Aug 21 18:30:25 EDT 2025 Fri Jul 11 12:01:12 EDT 2025 Fri Jul 25 10:13:54 EDT 2025 Tue Jun 17 22:02:33 EDT 2025 Wed Feb 19 02:25:41 EST 2025 Tue Jul 01 03:12:22 EDT 2025 Thu Apr 24 23:12:13 EDT 2025 Sun Jun 02 18:52:24 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0 Copyright © 2022 Xiao-Ying Lin et al. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c476t-42669fe79bbd65307e8d88643429697bdf3fb4ab4ee41953cef838d1f6f3a0b33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Academic Editor: Wei long Zhong |
ORCID | 0000-0002-3695-6990 0000-0002-8324-3635 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2022/4563523 |
PMID | 35432537 |
PQID | 2651412749 |
PQPubID | 4727241 |
PageCount | 15 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9007646 proquest_miscellaneous_2652034062 proquest_journals_2651412749 gale_infotracmisc_A700760095 pubmed_primary_35432537 crossref_primary_10_1155_2022_4563523 crossref_citationtrail_10_1155_2022_4563523 hindawi_primary_10_1155_2022_4563523 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-04-06 |
PublicationDateYYYYMMDD | 2022-04-06 |
PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-06 day: 06 |
PublicationDecade | 2020 |
PublicationPlace | Egypt |
PublicationPlace_xml | – name: Egypt – name: New York |
PublicationTitle | Journal of oncology |
PublicationTitleAlternate | J Oncol |
PublicationYear | 2022 |
Publisher | Hindawi John Wiley & Sons, Inc |
Publisher_xml | – name: Hindawi – name: John Wiley & Sons, Inc |
References | 22 23 24 26 27 28 29 30 31 10 11 12 13 14 15 16 17 18 19 J. Zi (25) 2017; 7 1 2 3 4 5 6 7 8 9 20 21 |
References_xml | – ident: 26 doi: 10.2147/OTT.S223321 – ident: 29 doi: 10.1007/s00011-020-01345-x – ident: 6 doi: 10.1016/j.biopha.2018.10.046 – ident: 8 doi: 10.1016/j.ccell.2016.05.007 – ident: 3 doi: 10.1056/NEJMra052603 – ident: 15 doi: 10.1080/15384101.2017.1407893 – ident: 30 doi: 10.1002/jgm.3074 – ident: 22 doi: 10.1186/s13045-016-0344-4 – ident: 27 doi: 10.1002/jcb.26231 – ident: 13 doi: 10.1089/dna.2016.3533 – ident: 24 doi: 10.1016/j.canlet.2019.04.030 – ident: 4 doi: 10.1186/s12943-017-0692-x – ident: 14 doi: 10.1038/s41419-019-1479-3 – ident: 16 doi: 10.2139/ssrn.3844927 – ident: 31 doi: 10.1016/j.biopha.2019.108965 – ident: 20 doi: 10.3324/haematol.2018.199364 – ident: 5 doi: 10.3892/or.2016.5147 – ident: 10 doi: 10.1177/0963689719887370 – ident: 28 doi: 10.1016/j.leukres.2019.106265 – ident: 2 doi: 10.1038/bcj.2017.53 – ident: 21 doi: 10.3390/ijms20020412 – ident: 11 doi: 10.1080/21691401.2019.1608221 – ident: 12 doi: 10.1002/jcp.27393 – ident: 19 doi: 10.3389/fphar.2016.00491 – volume: 7 start-page: 869 issue: 4 year: 2017 ident: 25 article-title: Treatment with the C-C chemokine receptor type 5 (CCR5)-inhibitor maraviroc suppresses growth and induces apoptosis of acute lymphoblastic leukemia cells publication-title: American Journal of Cancer Research – ident: 17 doi: 10.1186/s12967-019-1882-7 – ident: 9 doi: 10.1002/jcb.27918 – ident: 1 doi: 10.1056/NEJMra1400972 – ident: 18 doi: 10.3389/fgene.2021.656042 – ident: 23 doi: 10.1038/leu.2013.226 – ident: 7 doi: 10.1038/onc.2014.131 |
SSID | ssj0064096 |
Score | 2.2847002 |
Snippet | Acute lymphoblastic leukemia (ALL) is the most serious hematological carcinoma in adolescents. The significance of long noncoding RNAs (lncRNAs) and their... |
SourceID | pubmedcentral proquest gale pubmed crossref hindawi |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1 |
SubjectTerms | Acute lymphocytic leukemia Analysis Apoptosis Cancer therapies Cell growth Genes Leukemia Medical prognosis MicroRNA Pediatrics Survival analysis Tumor proteins |
SummonAdditionalLinks | – databaseName: Hindawi Publishing Open Access dbid: RHX link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEB9sQfFF_Da2lRXqkwQv2Y9sHs-j5ZD2ELFwb2F3s-GCNpFrDuk_4N_dmWRz9KqiT_ma_SCzk_kN89sJwHHGnXaqtLGV0saCsofGWxFrbXUljDGJpd3I5ws1vxCflnIZiiRd_Z7CR29H4Xn6Af08QgW-B3u4wCgony_HD67CEKXfRKTQXrSQk5HffqftjucJ39_7K4p8f9Z_wpd3aZK3_M7pY3gUACObDhp-Avd88xQenIeU-DP4RRa99quBiM7GIiOsrdjntiMuELb-WLeXxMNZ9_enbtN5dnaNimwtomfsmZ35zTd_WRtWN2wWNngze816SgEzbNbjazo_acp2qOzKviymbDHwyJ_DxenJ19k8Dj9XiJ3IVBeTZ84rn-XWlkqipXtdao34BB2UyjNbVryywljhvaBUm_OV5rpMKlVxM7Gcv4D9pm38K2CZxzBIY0ODupYODzKxia8w-BXcuUkE78cXX7hQeZx-gPG96CMQKQtSUxHUFMG7rfSPoeLGX-QOSYcFGSL25tAsXDHNhlRjLiM4Drr9Vy-j4otgvVdFqhBGJhiv5xG83T6mAYiR1nh8wySTTjjCoTSCl8M62Q7EpeCp5FkE2c4K2gpQTe_dJ0296mt75zR_oV7_3-wP4CFd9kwidQj73XrjjxAkdfZNbyI3QnIJOQ priority: 102 providerName: Hindawi Publishing – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1La9wwEBZtSksvoe-6SYsK6amYrK2nT2G7JISSLKU0sDdjyRJr0tjJxkvIH-jvzowtu93Sx8nGlmRbo9F84_k0ImRPMautLE1shDAxx-hh4QyPtTba86IoEoOrkU_n8viMf16IRfjhdh1olcOc2E3UZWPxH_l-KsG0J-BDZQeXVzHuGoXR1bCFxn3yAFOXIaVLLUaHS4Lv0q0ukqBImovJQHwXAn3-dB_AA-APtmGSwsT8cIku8U31J-D5O3_yF4N09IRsByRJp73on5J7rn5GHp2GWPlz8gNVfeWWPUOdDtlHaOPpl6ZFkhDU_lQ1F0jQWXXXp3bdOnpyCxJuDMBqaJmeuPW5u6gKWtV0FlZ-U3NLO64BLeisA954fliXTZ_ylX6dT-m8J5i_IGdHh99mx3HYdSG2XMk2RpOdeacyY0opYApwutQagAtYLpkpU3rmDS8Md45jDM46r5kuEy89KyaGsZdkq25q95pQ5cA_0lCxgEEgLBxEYhLnwSvmzNpJRD4OHZ_bkJIcd8b4nneuiRA5iikPYorIh7H0ZZ-K4y_ldlGGOWootGZBX2w-VX0MMhMR2Quy_V8rg-DzoNbX-c9BGJH34218AFLVagc9jGXSCQOclEbkVT9OxgcxwVkqmIqI2hhBYwFM9r15p66WXdLvDN-fyzf_fq0d8hg_oqMWyV2y1a7W7i2gpta861TjDueQE4U priority: 102 providerName: ProQuest |
Title | Comprehensive Analysis of Potential Biomarkers of Acute Lymphoblastic Leukemia in Children by Using a Competing Endogenous RNA Network |
URI | https://dx.doi.org/10.1155/2022/4563523 https://www.ncbi.nlm.nih.gov/pubmed/35432537 https://www.proquest.com/docview/2651412749 https://www.proquest.com/docview/2652034062 https://pubmed.ncbi.nlm.nih.gov/PMC9007646 |
Volume | 2022 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9NAEB_uA8UX8fOMnmWF80miTfczDyK90rPItRzFg76F7GZDi3eJ1hbtP-Df7Uw-ij1O9CVNmt1N2JnJ_Ib57SzAiebOOJXZ0EppQ0HZw9RbERpjTS7SNI0srUYeT9ToUnyaydketLuNNhP4_dbQjvaTulxevf35bfMBDf59ZfBSUvzee4dAALEE34dD9EmaTHQstvkEhVFMtc5IoUkZIbstBf5G7x3n1Hyi78wpOP6xuA2C3mRS_uGazh7A_QZTsn6tBA9hzxeP4O64yZo_hl9k9Es_r7nqrK1DwsqcXZQrogth79NFeU1UnWX1f9-tV56db1DWpUWAjSOzc7_-4q8XKVsUbNCsAWd2wyrWAUvZoILgdD4ssrIu_sqmkz6b1FTzJ3B5Nvw8GIXN_guhE1qtQnLece51bG2mJH4MvMmMQQiDPkzF2mY5z61IrfBeUDbO-dxwk0W5ynnatZw_hYOiLPwzYNpjpGSwY4rqIB3-yMhGPsf4WHDnugG8aSc-cU1xctoj4yqpghQpExJT0ogpgNfb1l_rohx_aXdMMkxIe3A0h5bjkr6us5GxDOCkke2_RmkFn7T6mfQUIs0IQ_o4gFfb2_QAIq0VHmeY2vS6HBFTL4CjWk-2D-JS8J7kOgC9o0HbBlT2e_dOsZhX5b9jen-hnv_f27-Ae3RZkY3UMRyslmv_EnHUynZgX890Bw5Ph5OLKV59nEWdymzwOB3NfgNJGhs0 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9NAEB5VqTheEDeGAovUPiGriffw-gGhNKRKaRJVVSv1zXjXayWitds0UZU_wM_hNzLjIxDE8dQnW_Ye9s7sHDvfzgJsh9xqq1LjGymNLyh6mDgjfK2NzkSSJB1Du5FHYzU4FZ_P5NkGfG_2whCsspGJpaBOC0tr5LuBQtXeQR8q-nh55dOpURRdbY7QqNji0C1v0GW7_nDwCem7EwT7_ZPewK9PFfCtCNXcJ5UUZS6MjEmVRBZ3OtUaFTNKZhWFJs14ZkRihHOCYkzWZZrrtJOpjCdtQwugKPI3BUdXpgWbe_3x0XEj-xV6S-V-JoVTVwvZbqD2UtIqQ7CL5gpaPHxNCdaq4M6EnPCb6Z9M3d8Rm7-owP2H8KC2XVm3YrZHsOHyx3B3VEfnn8A3Ei4zN6kw8azJd8KKjB0Vc4IlYe29aXFBkKBZ-bxrF3PHhkvkqcKgIY8ts6FbfHUX04RNc9ar95ozs2QluoElrFea-nTfz9OiSjLLjsddNq4g7U_h9FYo8gxaeZG7F8BChx6ZxooJsp20eJEd03EZ-uGCW9v24H0z8LGtk6DTWRzncekMSRkTmeKaTB7srEpfVsk__lJui2gYk0zA1izOUBt3wyrqGUkPtmva_q-VhvBxLUiu459s78G71WvqgMBxucMRpjJBm6NlFnjwvOKTVUdcCh5IHnoQrnHQqgClF19_k08nZZrxiL5fqJf__qy3cG9wMhrGw4Px4Su4Tz9UApvUFrTms4V7jTbb3LypJwqDL7c9N38ArVlR3A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamISZeEPeFDTDS9oSiNvElzgNCpVu1sa6aEJP6FmLHViNYsnWtpv4BfhS_jnNygyIuT3tKlDh2knP3-XxMyF7EjDIy074WQvscs4ep1dxXSivH0zQNNK5GPp3Io3P-YSqmG-R7uxYGYZWtTqwUdVYanCPvhRJMewAxVNxzDSzi7GD07vLKxx2kMNPabqdRs8iJXd1A-Hb99vgAaL0fhqPDT8Mjv9lhwDc8kgsfzVPsbBRrnUkB7G5VphQYadDSMo505pjTPNXcWo75JmOdYioLnHQs7WucDAX1fydiIkAZi6ZdsCchbqpWNkkQYsVFvwXdC4HzDWEPHBfwfdiaOWyMwt0ZhuM3-Z-c3t-xm78Yw9EDcr_xYumgZruHZMMWj8jWaZOnf0y-oZqZ21mNjqdt5RNaOnpWLhCgBE-_z8sLBAfNq-sDs1xYOl4Bd5UaXHromY7t8ou9yFOaF3TYrDqnekUrnANN6bBy-vH8sMjKutws_TgZ0EkNbn9Czm-FHk_JZlEWdpvQyEJspuDBFBhQGDiIQAfWQUTOmTF9j7xpf3ximnLouCvH16QKi4RIkExJQyaP7HetL-syIH9pt4s0TFA7QG8GZNUkg6jOf8bCI3sNbf_XS0v4pFEp18lPAfDI6-42DoAwucLCH8Y2YZ-BjxZ65FnNJ91ATHAWChZ5JFrjoK4BFhpfv1Pks6rgeIzvz-Xzf7_WK7IFEpmMjycnO-Qefk-FcJK7ZHMxX9oX4Lwt9MtKSij5fNti-QPGtlSs |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comprehensive+Analysis+of+Potential+Biomarkers+of+Acute+Lymphoblastic+Leukemia+in+Children+by+Using+a+Competing+Endogenous+RNA+Network&rft.jtitle=Journal+of+oncology&rft.au=Lin%2C+Xiao-Ying&rft.au=Yuen%2C+Ka-Yuk&rft.au=Chen%2C+Hai-Lei&rft.au=Shen%2C+Miao-Na&rft.date=2022-04-06&rft.pub=Hindawi&rft.issn=1687-8450&rft.eissn=1687-8450&rft.volume=2022&rft_id=info:doi/10.1155%2F2022%2F4563523&rft.externalDocID=10_1155_2022_4563523 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1687-8450&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1687-8450&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1687-8450&client=summon |